NetTargets Inc.
09 Jun 2021
NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.
We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.
NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.